SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+0.25%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$520M
AUM Growth
+$520M
(+0.68%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
129
New
9
Increased
50
Reduced
34
Closed
11
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$9.6M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$5.08M |
| 3 |
TSVT
2seventy bio
TSVT
|
$4.86M |
| 4 |
Treace Medical Concepts
TMCI
|
$4.7M |
| 5 |
Vera Therapeutics
VERA
|
$4.66M |
Top Sells
| 1 |
Exelixis
EXEL
|
$8.88M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$6.05M |
| 3 |
iRhythm Technologies
IRTC
|
$4.59M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$4.22M |
| 5 |
Arrowhead Research
ARWR
|
$3.87M |
Sector Composition
| 1 | Healthcare | 95.06% |
| 2 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alkermes
ALKS
$4.95B
| $6.51M | 1.25% |
231,100
-800
| -0.3% | -$22.6K |
|
27
Inspire Medical Systems
INSP
$2.53B
| $6.44M | 1.24% |
27,500
+9,300
| +51% | +$2.18M |
|
28
Pfizer
PFE
$141B
| $6.42M | 1.23% |
157,400
+28,000
| +22% | +$1.14M |
|
29
AbbVie
ABBV
$374B
| $6.26M | 1.2% |
39,300
+2,000
| +5% | +$319K |
|
|
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.18M | 1.19% |
114,200
-8,250
| -7% | -$447K |
|
31
Tenet Healthcare
THC
$16.5B
| $6.03M | 1.16% |
101,500
| – | – |
|
|
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6M | 1.15% |
109,950
+22,304
| +25% | +$1.22M |
|
33
Prothena Corp
PRTA
$452M
| $5.95M | 1.14% |
122,750
+7,550
| +7% | +$366K |
|
34
Merck
MRK
$210B
| $5.85M | 1.12% |
55,000
| – | – |
|
35
Amicus Therapeutics
FOLD
$2.42B
| $5.77M | 1.11% |
519,982
+12,300
| +2% | +$136K |
|
36
Denali Therapeutics
DNLI
$2.24B
| $5.64M | 1.08% |
244,850
+1,000
| +0.4% | +$23K |
|
37
Arvinas
ARVN
$580M
| $5.6M | 1.08% |
205,114
-34,133
| -14% | -$933K |
|
|
BLU
38
DELISTED
BELLUS Health Inc.
BLU
| $5.53M | 1.06% |
767,829
+98,800
| +15% | +$711K |
|
|
BPMC
39
DELISTED
Blueprint Medicines
BPMC
| $5.48M | 1.05% |
121,900
+6,000
| +5% | +$270K |
|
|
GRTX
40
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $5.37M | 1.03% |
2,098,565
+431,899
| +26% | +$1.11M |
|
41
Arcus Biosciences
RCUS
$1.24B
| $5.36M | 1.03% |
293,646
+55,164
| +23% | +$1.01M |
|
42
Alnylam Pharmaceuticals
ALNY
$58.6B
| $5.32M | 1.02% |
26,570
+3,760
| +16% | +$753K |
|
43
Amgen
AMGN
$153B
| $5.3M | 1.02% |
21,920
+4,000
| +22% | +$967K |
|
|
CTIC
44
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $5.26M | 1.01% |
1,253,300
+273,000
| +28% | +$1.15M |
|
45
ARS Pharmaceuticals
SPRY
$1.08B
| $5.17M | 0.99% |
793,587
+11,177
| +1% | +$72.8K |
|
46
Boston Scientific
BSX
$159B
| $5.1M | 0.98% |
101,976
-12,000
| -11% | -$600K |
|
|
KRTX
47
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.88M | 0.94% |
26,880
+5,070
| +23% | +$921K |
|
|
TSVT
48
DELISTED
2seventy bio
TSVT
| $4.86M | 0.93% |
+476,000
| New | +$4.86M |
|
|
MRTX
49
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.77M | 0.92% |
128,406
+61,560
| +92% | +$2.29M |
|
|
50
Vera Therapeutics
VERA
$1.47B
| $4.66M | 0.9% |
+600,300
| New | +$4.66M |
|